BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35638441)

  • 1. Palovarotene inhibits the NF-κB signalling pathway to prevent heterotopic ossification.
    Huang J; Wu J; Lin J; Li C; Tang B; Xiao H
    Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):881-892. PubMed ID: 35638441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-
    Huang J; Lin J; Li C; Tang B; Xiao H
    Stem Cells Int; 2022; 2022():1560943. PubMed ID: 35530413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model.
    Pavey GJ; Qureshi AT; Tomasino AM; Honnold CL; Bishop DK; Agarwal S; Loder S; Levi B; Pacifici M; Iwamoto M; Potter BK; Davis TA; Forsberg JA
    Bone; 2016 Sep; 90():159-67. PubMed ID: 27368930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
    Sinha S; Uchibe K; Usami Y; Pacifici M; Iwamoto M
    Bone; 2016 Sep; 90():59-68. PubMed ID: 26891836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification.
    Wheatley BM; Cilwa KE; Dey D; Qureshi AT; Seavey JG; Tomasino AM; Sanders EM; Bova W; Boehm CA; Iwamoto M; Potter BK; Forsberg JA; Muschler GF; Davis TA
    J Orthop Res; 2018 Apr; 36(4):1135-1144. PubMed ID: 28960501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification.
    Huang J; Liu D; Zhang J; Xiao H
    Front Med (Lausanne); 2022; 9():897392. PubMed ID: 35646981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palovarotene: First Approval.
    Hoy SM
    Drugs; 2022 Apr; 82(6):711-716. PubMed ID: 35384641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity.
    Lees-Shepard JB; Nicholas SE; Stoessel SJ; Devarakonda PM; Schneider MJ; Yamamoto M; Goldhamer DJ
    Elife; 2018 Sep; 7():. PubMed ID: 30226468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance.
    Liu F; Zhao Y; Pei Y; Lian F; Lin H
    Cell Commun Signal; 2024 Mar; 22(1):159. PubMed ID: 38439078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrine attenuates heterotopic ossification by suppressing TGF-β induced mesenchymal stromal cell migration and osteogenic differentiation.
    Mao D; Pan X; Rui Y; Li F
    Biomed Pharmacother; 2020 Jul; 127():110152. PubMed ID: 32559842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 coordinates NF-κB signaling pathway to promote chondrogenic differentiation of tendon cells in heterotopic ossification.
    Fu J; Zhang J; Jiang T; Ao X; Li P; Lian Z; Li C; Zhang X; Liu J; Huang M; Zhang Z; Wang L
    Bone; 2022 Oct; 163():116507. PubMed ID: 35908648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-κB Signaling-Mediated Crosstalk Between Macrophages and Preosteoblasts by Metformin Alleviates Trauma-Induced Heterotopic Ossification.
    Hou J; Chen J; Fan J; Tang Z; Zhou W; Lin H
    Inflammation; 2023 Aug; 46(4):1414-1429. PubMed ID: 37115368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIPUS inhibited the expression of inflammatory factors and promoted the osteogenic differentiation capacity of hPDLCs by inhibiting the NF-κB signaling pathway.
    Liu S; Zhou M; Li J; Hu B; Jiang D; Huang H; Song J
    J Periodontal Res; 2020 Jan; 55(1):125-140. PubMed ID: 31541455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice.
    Peterson JR; Eboda ON; Brownley RC; Cilwa KE; Pratt LE; De La Rosa S; Agarwal S; Buchman SR; Cederna PS; Morris MD; Wang SC; Levi B
    Stem Cells Dev; 2015 Jan; 24(2):205-13. PubMed ID: 25122460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human osteoprogenitor cells obtained from traumatic heterotopic ossification samples showed enhanced osteogenic differentiation potential and ERK/hedgehog signaling than that from normal bone.
    Zhang T; Li J; Sun Z; Tu B; Wang W; Luo G; He Y; Jiang S; Fan C
    IUBMB Life; 2022 Nov; 74(11):1081-1093. PubMed ID: 35964153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
    Pignolo RJ; Baujat G; Hsiao EC; Keen R; Wilson A; Packman J; Strahs AL; Grogan DR; Kaplan FS
    J Bone Miner Res; 2022 Oct; 37(10):1891-1902. PubMed ID: 35854638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in mice.
    Wang H; Song D; Wei L; Huang L; Wei D; Su Y; Liang J; Lian H; Zhao J; Liu Q
    Biomed Pharmacother; 2023 May; 161():114508. PubMed ID: 37002582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
    Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
    J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.